1. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs;Ehrenforth;Lancet,1992
2. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of haemophilia A;Schwartz;N Engl J Med,1990
3. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy and inhibitor risk in previously untreated individuals with hemophilia A;Bray;The Recombinate Study Group Blood,1994
4. A four-year update of safety and efficacy of an albumin-free formulated B-domain deleted factor VIII (BBD rFVIII, rVIIISQ) in previously untreated severe hemophilia A patients;Lusher;Thromb Haemost,1999
5. Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity;Ljung;Br J Haematol,2001